Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058955 · ClinicalTrials.gov registry record · Phase 1
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
A Phase 1 study of Sedative Abuse, sponsored by Orphan Medical.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00058955: Completed Phase 1 study of Sedative Abuse, sponsored by Orphan Medical.
NCT00058955 is a Phase 1 study of Sedative Abuse that has completed, run by Orphan Medical. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00058955, a Phase 1 study of Sedative Abuse, has completed, sponsored by Orphan Medical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about the effects of gamma-hydroxybutyric acid (GHB) by comparing its physiological, behavioral and subjective effects with those of several other drugs.
Conditions Studied
Interventions
- DRUG sodium oxybate, triazolam and pentobarbital
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine/Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-03 |
| Phase | Phase 1 |
What the finished NCT00058955 record still lists
NCT00058955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Sedative Abuse appearing as the primary indexed condition, and to 1 intervention - of which sodium oxybate, triazolam and pentobarbital is the first listed.
NCT00058955 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00058955 about?
NCT00058955 is a clinical study titled "Physiological, Behavioral and Subjective Effects of Drugs (GHB)". The purpose of this study is to learn more about the effects of gamma-hydroxybutyric acid (GHB) by comparing its physiological, behavioral and subjective effects with those of several other drugs.
What is the current status of trial NCT00058955?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2003-08. Estimated completion is 2005-03.
What conditions does trial NCT00058955 study?
This clinical trial studies the following conditions: Sedative Abuse.
What interventions are being tested in trial NCT00058955?
The interventions under investigation include: sodium oxybate, triazolam and pentobarbital (DRUG).
Who is sponsoring clinical trial NCT00058955?
This trial is sponsored by Orphan Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00058955 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00058955's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia